AstraZeneca Pharma Soars 20% on New Drug Launch

AstraZeneca Pharma India shares soared 20 per cent to its maximum intraday limit on Thursday after the company said that it has launched a new drug for treatment of type 2 diabetes mellitus.   In a statement issued to exchanges, AstraZeneca Pharma said that it has launched "Forxiga, a breakthrough treatment for type 2 diabetes mellitus."   The company said Forxiga is a "highly selective inhibitor of sodium-glucose contransporter 2. ...